Research Grant Recipients

For additional information about the Skin of Color Society (SOCS) Research Grant please visit this page

SOCS Research Grant Recipients & Projects


Hyejin Leah Chung, MD
Fractional CO2 Laser versus Fractional Radiofrequency Microneedling for Hidradenitis Suppurativa-Related Atrophic Scars: A Randomized Controlled Rater-Blinded Study

Jennifer Fernandez, MD, RD
Teledermatology in Kenya: An Assessment of Provider Preferences

Nazgol Sadat Haddadi, MD, MPH
The role of Type I IFNs on Keratinocyte’s response to Ultraviolet Light B in Photosensitive Skin Diseases

Courtney Johnson, MD, PhD
Single Cell Transcriptomic View of Cancer-Associated Fibroblasts in Early-Stage Mycosis Fungoides

Tasneem Mohammad
Exploring the clinical, spectroscopic, histologic, and immunohistochemical features of post-inflammatory hyperpigmentation using disease specific validated in-vivo models with comparison to ultraviolet b induced skin pigmentation

The 2023 SOCS Research Grants were made possible thanks to the support from Bristol Myers Squibb, L’Oréal and Pfizer.


Jillian Richmond, PhD
Examining Gene and Protein Expression in Clinically Diverse Mycosis Fungoides Samples From Skin of Color Patients

Shawn Shih, MD
The Utility of Topical Oxymetazoline in Preventing Post-filler Ecchymosis in Skin of Color Patients: A Randomized, Double-blind, Split-Face Study

Nkemjika Ugonabo, MD, MPH
Combination Topical Cysteamine and Fractional 1927nm Low-Powered Diode Laser Resurfacing vs. Topical Cysteamine Alone in the Treatment of Melasma: A Prospective, Split-Face Cohort Study

The 2022 SOCS Research Grants were made possible thanks to the support from Pfizer.

Courtney Johnson, MD, PhD
Investigating the Molecular Differences of Cutaneous T-Cell Lymphomas in Black Women for Personalized Therapeutic Options

Nayoung Lee, MD
Laser-Assisted Delivery of 5-Fluorouracil versus Triamcinolone in the Treatment of Keloids

The 2021 SOCS Research Grants were made possible thanks to the support from OrthoDermatologics and Pfizer.

Tarannum Jaleel, MD, MHSc
Racial Variation in the Effect of Sex Hormones in Hidradenitis Suppurativa

Maggi Ahmed, MD, MSc
Melanocyte Transplantation Plus Topical JAK Inhibitor or Tacrolimus for Treatment of Vitiligo: A Randomized Comparative Study

Crystal Aguh, MD
Investigating the Role of Metabolic Dysregulation in the Pathogenesis of CCCA

Shawn G. Kwatra, MD
Molecular Basis of Itch in African Americans

Temitayo A. Ogunleye, MD
Molecular Analysis of Central Centrifugal Cicatricial Alopecia

Courtney Bagayoko, MD
Treatment outcomes for patients with Central Centrifugal Cicatricial Alopecia (CCCA)

Giang-Huong Nguyen, MD
MicroRNA Expression Profiling of Acral Melanoma in Asian Population

Steven H. Yang, MD, PhD
Epigenetic Changes in Ethnic Human Skin During Skin Aging

Jenna O’Neil, MD
Genetic Factors in CCCA

Nada Elbuluk MD, MS
Stretch Stimulus on Melanocyte Function and Dyspigmentation in Human Skin in Vivo: A Pilot Study on Striae Distensae

Donald A. Glass, II, MD, PhD
Uncovering the Genetic Causes of Keloid Formation

Ammar Ahmed, MD
A Randomized, Double-Blinded, Placebo-Controlled Trial of Oral Polypodium Leucotomos Extract as an Adjunct to Sunscreen in the Treatment of Melasma

Ginette A. Hinds (Okoye), MD
Improving acne keloidalis nuchae with targeted ultraviolet B treatment: a prospective, randomized, split-scalp comparison study

John E. Harris, MD, PhD
T cells in mouse model of vitiligo

Roopal V. Kundu, MD
Development and Validation of a Vitiligo-specific Quality of Life Instrument (VitiQol)

Newsletter Icon

Research Award

Click here for more information on the Valeant Research Award.

Learn More

Curtis Icon

Cutis Journal

Read published peer-reviewed articles written your by Skin of Color Society members

Newsletter Icon

Join Our Newsletter

Stay up-to-date on the latest news and happenings related to The Skin of Color Society.

Did you know Icon

Did You Know

Skin of color patients comprise the majority in California, New Mexico and Texas…and soon will be the majority in Arizona, Nevada, Georgia, New York and Florida.

By 2042, more than 50% of the US population will have skin of color.